EMEA-002077-PIP01-16-M05
Key facts
| Invented name |
Ultomiris
|
| Active substance |
ravulizumab
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0191/2022
|
| PIP number |
EMEA-002077-PIP01-16-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of paroxysmal nocturnal haemoglobinuria
|
| Route(s) of administration |
|
| Contact for public enquiries |
Alexion Europe SAS
E-mail: pip.enquiries.eu@alexion.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|